American Liver Foundation’s Post

Practices in The Network have been at the forefront of clinical research for over two decades, giving patients access to cutting-edge trials while receiving care locally. For patients like Debbie, trials like these have been a literal lifesaver, allowing her to survive and enjoy precious moments with her grandchildren. Read more in our annual report ➡️ https://lnkd.in/g2khrtTR #ClinicalTrials #ClinicalResearch #CommunityOncology

https://lnkd.in/gjnrfznr to the Caring Connections Program If you or a loved one is going to have a transplant or CAR T-cell therapy, chances are you're feeling scared and overwhelmed. BMT InfoNet's Caring Connections Program can help! Talk with someone who: has been through a transplant, CAR T-cell therapy, or experienced GVHD. #BMTinfonet #GVHD #CarTcell #CaringConnections #SurvivorshipSymposium #stemcelltransplantsurvivor

Today is about showing others that you care for them, whether in small ways or grand gestures. At Onco360, our patients are at the heart of everything we do. Every interaction is filled with a dose of care, kindness, and most of all – compassion. Learn more at https://lnkd.in/eECvStpW. #OncologyPharmacy #ValentinesDay

If you are visiting your GP or health care professional and would like a referral to one of our medical oncologists or genetic counselors, our referral forms are available at any time on the Tasman Health Care website >> #oncologyreferral #geneticcounselling #TasmanHealthCare #CommittedToCare #InnovationInHealth #cancertreatment #clinicialtrials #oncology #cancerresearch #dayinfusionunit

2023 American Heart Association focused update on adult #ACLS: organ donation 🧠 should be considered in all patients resuscitated from cardiac arrest meeting neurological criteria for death 🫀should be considered in all patients resuscitated from cardiac arrest before planned WLST 📈is an important outcome that should be considered in developing/evaluating systems of care 🔓https://bit.ly/3tof4PK

Home death was not the preferred place for a large number of patients when this option was presented within a clinical context scenario. The PPoD and actual place-of-death were depending on the clinical situation. During the curse of illness, 6.3% of patients change their PPoD in at least one of end-of-life scenario. https://lnkd.in/dR6ygF9E

Day 2 of EPHMRA conference, and really moved by a personal, emotional, and engaging presentation by anthony rowbottom from about his personal cancer journey as a young father of two. Some takeaways: - Think about your underserved populations. As I've been saying, AI can probably save you time by telling you a lot about the "normal" patients. Use the time saved to learn more about the less likely cases. - Talk to primary caregivers and nurses. There is always SO much more to a patient journey than medical treatment. - The journey is always emotional. If you aren't looking at that angle, you are missing 90% of the pitcture. #ephmra #insights #pharma

Are you curious about Palliative Care? Watch (or listen to) Hodgkin's International's latest presentation and learn about how palliative care is used to improve the quality of life of cancer survivors and their families.

https://lnkd.in/d8ixuB9z Palliative Care is a complex care: together with Silvia Tanzi and Carlo Peruselli here is our opinion about Prof Bruera and Prof Mercadante's review on Acute Palliative Care Units in Cancer Centers

New phase 3 data on #linaclotide for functional #constipation in pediatric patients aged 6 to 17 years. Linaclotide-treated patients achieved a greater than 2-fold least squares mean change from baseline in SBMs/week (2.220) vs placebo (1.050) (P < 0.0001). MORE: https://lnkd.in/ep5NY9HS